Re:Toshiba device tests cancer types from a drop of blood
by BiteCode_dev on Monday November 25, 2019 @06:33PM
(#21634089)
This is true for any medical act you perform on a massive scale really. Including vaccination, supplementation, etc. Everything is a cost/benefit ratio.
[ Parent
| on HN ]
Re:Toshiba device tests cancer types from a drop of blood
by tptacek on Monday November 25, 2019 @06:58PM
(#21634270)
Yes, and this math has been done on many of those interventions (certainly for vaccination) and the benefit holds up. That statistical base rates are problematic for cancer detection is a pretty well-understood problem.